Amelia Fawcett
About Amelia C. Fawcett
Amelia C. Fawcett, age 68, has served on State Street’s Board since 2006 and was the independent Lead Director from 2019 until the planned transition following the 2025 annual meeting. She holds a B.A. from Wellesley College and a J.D. from the University of Virginia, and brings deep global financial services, risk oversight, and regulatory experience to the Board. She is a U.S. and U.K. citizen.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Morgan Stanley | Vice Chairman; COO of EMEA Operations; other senior roles | 1987–2006 | Senior leadership in global finance and operations; regulatory and corporate affairs exposure |
| Kinnevik AB (Nasdaq Stockholm) | Director and Chairman | 2018–2021 | Led governance and strategic oversight at long-term investment company |
| Standard Board for Alternative Investments (U.K.) | Chairman | 2011–2021 | Set standards and oversight in alternative investments |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Bermuda Monetary Authority | Financial Policy Council Member | 2016–present | Regulatory advisory exposure |
| Royal Botanic Garden, Kew | Chair | Not disclosed | Governance leadership in major cultural institution |
| International Advisory Panel on Biodiversity Credits | Co-Chair | Not disclosed | ESG and biodiversity market development |
| Circular Bioeconomy Alliance | Chair | Not disclosed | Sustainability strategy leadership |
| HM Treasury (U.K.) | Former Non-Executive Director | Not disclosed | Public sector finance oversight |
| Bank of England | Former Member, Court of Directors | Not disclosed | Central bank governance experience |
| Wellcome Trust | Former Governor | Not disclosed | Biomedical philanthropy governance |
| The Prince of Wales’s Charitable Foundation | Former Chairman | Not disclosed | Philanthropic leadership |
| Project HOPE UK | Trustee | Not disclosed | Non-profit governance |
Board Governance
- Independence: Independent director; Board determined all non-management nominees (including Fawcett) meet NYSE independence standards and Corporate Governance Guidelines.
- Lead Independent Director: Served as Lead Director since 2019; Board appointed Sara Mathew as Lead Director to begin after the 2025 annual meeting (subject to re-election).
- Committee assignments: Executive Committee; Human Resources Committee; Nominating and Corporate Governance Committee.
- Attendance/Engagement: Board met seven times in 2024; each director attended at least 75% of meetings. Fawcett states she attended every Board meeting and substantially all committee meetings, maintaining a visible independent leadership presence.
- Executive sessions: Independent directors meet in executive session at every regularly scheduled Board meeting, presided over by the Lead Director.
- Governance duties: As Lead Director, responsibilities include agenda setting with the Chair, presiding over executive sessions, liaising with management, CEO performance review, stakeholder and regulator engagement, and participation across all committee meetings to strengthen oversight.
Fixed Compensation
-
Director compensation framework (Board year 2024–2025): | Component | Value (USD) | Vehicle | |---|---:|---| | Annual Retainer | $100,000 | Cash or common stock | | Annual Equity Award | $195,000 | Common stock | | Additional Lead Director Retainer | $130,000 | Cash or common stock | | E&A and Risk Committee Chair Retainers | $40,000 | Cash or common stock | | HRC and Tech & Ops Committee Chair Retainers | $35,000 | Cash or common stock | | Nominating & Corporate Governance Chair Retainer | $25,000 | Cash or common stock | | E&A and Risk Committee Member Retainers | $20,000 | Cash or common stock |
-
Meeting fees: $1,500 per meeting after the tenth Board meeting; expense reimbursement for Board service.
-
Deferrals: Directors may elect to defer 0% or 100% of retainers, annual equity awards, and/or meeting fees; deferred cash credited to notional funds; deferred stock adjusted for dividend reinvestment; payouts on separation (lump sum or 2–5 year installments).
-
Amelia C. Fawcett – 2024 actual director compensation: | Item | Amount (USD) | |---|---:| | Fees Earned/Paid in Cash | $230,000 | | Stock Awards (value) | $195,011 | | All Other Compensation | — (not reported; under $10,000) | | Total | $425,011 | | Equity Grant Detail | 2,514 shares at $77.57 on May 15, 2024 | |
Performance Compensation
- Structure: Non-management director equity grants are common stock that vest immediately; no disclosed performance metrics, options, or PSUs for director compensation.
- Performance metric table (directors): | Performance Vehicle | Metric(s) | Payout Range | Vesting | |---|---|---|---| | Director Equity Grants | None (time-only); common stock | N/A | Immediate |
Note: Performance-based RSUs and long-term metrics (Pre-Tax Margin, Fee Revenue Growth; TSR modifier; ROE downside test) apply to Named Executive Officers, not directors.
Other Directorships & Interlocks
| Company | Status | Role | Notes |
|---|---|---|---|
| Kinnevik AB | Former | Director and Chairman | 2011–2021; no current public boards listed for Fawcett |
- Current public company boards: None disclosed for Fawcett; several other State Street directors hold external public boards, but no disclosed interlocks indicating conflicts for Fawcett.
Expertise & Qualifications
- Global financial services leadership; risk and regulatory oversight; strategic and corporate affairs experience.
- Education: Wellesley College (B.A.); University of Virginia (J.D.).
- Recognitions: Commander of the Order of the British Empire; Dame Commander of the Order of the British Empire; Commander of the Royal Victorian Order.
Equity Ownership
| Item | Detail |
|---|---|
| Beneficial Ownership (as of Mar 3, 2025) | 59,297 shares; each listed director individually owned less than 1% of outstanding shares (288,590,984 shares outstanding). |
| Unvested Director Stock | None (director stock awards vest immediately; no unvested awards at 12/31/2024). |
| Stock Ownership Guidelines (Directors) | 8x annual retainer ($800,000); hold all net shares until guideline met. |
| Compliance Status | As of Mar 3, 2025, all non-management directors other than the newly added Halliday exceeded full guideline levels; Halliday exceeded pro-rated level. |
| Hedging/Pledging Policy | Prohibited: short selling, hedging, options trading, pledging, speculative transactions in State Street securities. |
Governance Assessment
- Board effectiveness: Fawcett’s Lead Director tenure strengthened coordination across six standing committees, with full Board meeting attendance and near-full committee participation—signals strong oversight and engagement.
- Independence and conflicts: Board confirmed independence of all non-management nominees; no material relationships disclosed for Fawcett; related-person transactions policy reports none requiring disclosure beyond one management-relative employment case.
- Director pay alignment: Mix emphasizes time-based common stock and cash retainers; no performance-linked director equity—typical for large financials; deferral options reinforce long-term alignment.
- Ownership alignment: Fawcett exceeds director ownership guideline; trading policy bans hedging/pledging—positive alignment.
- Shareholder sentiment: 2024 Say-on-Pay approval ~93%; Board conducts regular shareholder outreach, with committee leadership participation—positive governance signal.
- RED FLAGS: None disclosed specific to Fawcett—no pledging, no related-party exposure, strong attendance; director equity immediately vests but without performance hurdles (common practice). Continue monitoring interlocks given extensive external roles, though no specific conflicts disclosed.